JP Morgan Comments on 4Q Results for Abbott Laboratories

JP Morgan published a research report today providing color on Abbott Laboratories'

4Q earning results. The investment firm has a Neutral rating on Abbott Laboratories. In the report, JP Morgan writes, "Abbott reported 4Q results this morning that were mostly in line with Street consensus. EPS of $1.45 (+11.8%) were a penny above consensus and in line with our thinking. Revenues of $10.377B were up 4.1% reported and 3.8% organic. On a reported basis, sales were $253M below the Street and $112M below our forecast" Shares of Abbott Laboratories are currently trading at $55.04, down 1.68% from yesterday's close.